165 related articles for article (PubMed ID: 9199508)
1. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
Ray P; Ghosh SK; Zhang DH; Ray A
FEBS Lett; 1997 Jun; 409(1):79-85. PubMed ID: 9199508
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.
Kurebayashi S; Miyashita Y; Hirose T; Kasayama S; Akira S; Kishimoto T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):11-7. PubMed ID: 9182853
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.
Ray A; Prefontaine KE; Ray P
J Biol Chem; 1994 Apr; 269(17):12940-6. PubMed ID: 8175711
[TBL] [Abstract][Full Text] [Related]
5. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.
Stein B; Yang MX
Mol Cell Biol; 1995 Sep; 15(9):4971-9. PubMed ID: 7651415
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
Galien R; Garcia T
Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
[TBL] [Abstract][Full Text] [Related]
7. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
8. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
[TBL] [Abstract][Full Text] [Related]
9. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation.
Dokter WH; Koopmans SB; Vellenga E
Leukemia; 1996 Aug; 10(8):1308-16. PubMed ID: 8709636
[TBL] [Abstract][Full Text] [Related]
10. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation.
Sun WH; Keller ET; Stebler BS; Ershler WB
Biochem Biophys Res Commun; 1998 Mar; 244(3):691-5. PubMed ID: 9535726
[TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL)-1 and IL-4 synergistically stimulate NF-IL6 activity and IL-6 production in human mesangial cells.
Nakazato Y; Hayashida T; Kanno Y; Sasamura H; Okada H; Suzuki H; Saruta T
Kidney Int; 1998 Jul; 54(1):71-9. PubMed ID: 9648065
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen.
Hao H; d'Alincourt-Salazar M; Kelley KM; Shatnawi A; Mukherjee S; Shah YM; Ratnam M
Oncogene; 2007 Dec; 26(57):7872-84. PubMed ID: 17599049
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of interleukin-8 gene expression.
Mukaida N; Okamoto S; Ishikawa Y; Matsushima K
J Leukoc Biol; 1994 Nov; 56(5):554-8. PubMed ID: 7525815
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines.
Takeshita S; Gage JR; Kishimoto T; Vredevoe DL; MartÃnez-Maza O
J Immunol; 1996 Apr; 156(7):2591-8. PubMed ID: 8786324
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes.
Matsui H; Ihara Y; Fujio Y; Kunisada K; Akira S; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 1999 Apr; 42(1):104-12. PubMed ID: 10435001
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.
Faggioli L; Costanzo C; Merola M; Bianchini E; Furia A; Carsana A; Palmieri M
Eur J Biochem; 1996 Aug; 239(3):624-31. PubMed ID: 8774705
[TBL] [Abstract][Full Text] [Related]
17. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation].
Fujikawa K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):563-74. PubMed ID: 1427600
[TBL] [Abstract][Full Text] [Related]
18. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
19. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B.
Zhang Y; Broser M; Rom WN
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2225-9. PubMed ID: 8134378
[TBL] [Abstract][Full Text] [Related]
20. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.
Ray A; Prefontaine KE
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):752-6. PubMed ID: 8290595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
